drugset / Trial / NCT03004469

Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

NCT03004469

Phase 3 Completed 458 enrolled Polichem S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to confirm the clinical efficacy and the safety of P-3074 in participants with androgenetic alopecia.

Timeline

Start
2016-08-02
Primary completion
2018-03-05
Completion
2018-03-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Finasteride Small molecule 1 mg Oral
Subject P-3074 Unknown 0.25 % Topical

Indications